Non-contrast Enhanced MRI for Evaluation of Breast Lesions. Comparison of Non-contrast Enhanced High Spectral and Spatial Resolution (HiSS) Images Versus Contrast Enhanced Fat-suppressed Images.

Academic Radiology

Volumn 18, Issue 12, 2011, Pages 1467-1474

  Medved, Milica ^a   Fan, Xiaobing ^a   Abe, Hiroyuki ^a   Newstead, Gillian M ^a   Wood, Abbie M ^a   Shimauchi, Akiko ^a   Kulkarni, Kirti ^a   Ivancevic, Marko K ^b   Pesce, Lorenzo L ^a   Olopade, Olufunmilayo I ^a   Karczmar, Gregory S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Breast cancer; Breast lesion; Contrast agent induced nephrotoxicity; Echo planar spectroscopic imaging; High spectral and spatial resolution (HiSS) imaging

Indexed keywords

CONTRAST MEDIUM;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCED FAT SUPPRESSED T1 WEIGHTED IMAGING; CONTRAST ENHANCEMENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; NON CONTRAST ENHANCED HIGH SPECTRAL AND SPATIAL RESOLUTION MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY;

AGED; BREAST DISEASES; BREAST NEOPLASMS; CONTRAST MEDIA; FATS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 80055120404     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.07.017     Document Type: Article

References (36)

1. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89.
2. Swayampakula A.K., Dillis C., Abraham J. Role of MRI in screening, diagnosis and management of breast cancer. Exp Rev Anticancer Ther 2008, 8:811-817.
3. Warner E., Messersmith H., Causer P., et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008, 148:671-679.
4. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
5. Huang W., Fisher P.R., Dulaimy K., et al. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004, 232:585-591.
6. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004, 292:2735-2742.
7. Kuhl C.K., Schild H.H., Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 2005, 236:789-800.
8. Kneeshaw P.J., Lowry M., Manton D., et al. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging. Breast 2006, 15:29-38.
9. Penn A., Thompson S., Brem R., et al. Morphologic blooming in breast MRI as a characterization of margin for discriminating benign from malignant lesions. Acad Radiol 2006, 13:1344-1354.
10. Perazella M.A. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Safety 2008, 3:67-75.
11. Fan X., Abe H., Medved M., et al. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J Magn Reson Imaging 2006, 24:1311-1315.
12. Medved M., Newstead G.M., Abe H., et al. High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. AJR Am J Roentgenol 2006, 186:30-37.
13. Karczmar G.S., Du W., Medved M., et al. Spectrally inhomogeneous effects of contrast agents in breast lesion detected by high spectral and spatial resolution MRI. Acad Radiol 2002, 9(suppl):S352-S354.
14. Foxley S., Fan X., Mustafi D., et al. Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images. Magn Reson Med 2009, 61:291-298.
15. Harms S.E., Flamig D.P., Hesley K.L., et al. Fat-suppressed three-dimensional MR imaging of the breast. Radiographics 1993, 13:247-267.
16. Soderstrom C.E., Harms S.E., Copit D.S., et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996, 201:427-432.
17. Du W., Du Y.P., Bick U., et al. Breast MR imaging with high spectral and spatial resolutions: preliminary experience. Radiology 2002, 224:577-585.
18. Medved M., Du W., Zamora M.A., et al. The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast. J Magn Reson Imaging 2003, 18:442-448.
19. Medved M., Newstead G.M., Fan X., et al. Fourier component imaging of water resonance in the human breast provides markers for malignancy. Phys Med Biol 2009, 54:5767-5779.
20. Medved M., Newstead G.M., Fan X., et al. Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast. Magn Reson Med 2004, 52:193-196.
21. Pinker K., Grabner G., Bogner W., et al. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol 2009, 44:553-558.
22. Jansen S.A., Fan X., Medved M., et al. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study. Phys Med Biol 2010, 55:N473-N485.
23. Medved M., Newstead G.M., Abe H., et al. Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage. Magn Reson Imaging 2010, 28:16-21.
24. Medved M., Ivancevic M.K., Olopade O.I., et al. Echo-planar spectroscopic imaging (EPSI) of the water resonance structure in human breast using sensitivity encoding (SENSE). Magn Reson Med 2010, 63:1557-1563.
25. Doyle M., Mansfield P. Chemical-shift imaging: a hybrid approach. Magn Reson Med 1987, 5:255-261.
26. Mansfield P. Spatial mapping of the chemical shift in NMR. Magn Reson Med 1984, 1:370-386.
27. Dorfman D.D., Berbaum K.S., Metz C.E. Receiver operating characteristic rating analysis. Generalization to the population of readers and patients with the jackknife method. Invest Radiol 1992, 27:723-731.
28. Dorfman D.D., Berbaum K.S., Lenth R.V., et al. Monte Carlo validation of a multireader method for receiver operating characteristic discrete rating data: factorial experimental design. Acad Radiol 1998, 5:591-602.
29. Hillis S.L., Berbaum K.S. Power estimation for the Dorfman-Berbaum-Metz method. Acad Radiol 2004, 11:1260-1273.
30. Hillis S.L., Berbaum K.S. Monte Carlo validation of the Dorfman-Berbaum-Metz method using normalized pseudovalues and less data-based model simplification. Acad Radiol 2005, 12:1534-1541.
31. Hillis S.L., Obuchowski N.A., Schartz K.M., et al. A comparison of the Dorfman-Berbaum-Metz and Obuchowski-Rockette methods for receiver operating characteristic (ROC) data. Stat Med 2005, 24:1579-1607.
32. Hillis S.L. A comparison of denominator degrees of freedom methods for multiple observer ROC analysis. Stat Med 2007, 26:596-619.
33. Hillis S.L., Berbaum K.S., Metz C.E. Recent developments in the Dorfman-Berbaum-Metz procedure for multireader ROC study analysis. Acad Radiol 2008, 15:647-661.
34. Pesce L.L., Metz C.E. Reliable and computationally efficient maximum-likelihood estimation of " proper" binormal ROC curves. Acad Radiol 2007, 14:814-829.
35. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993, 187:493-501.
36. Soderstrom C.E., Harms S.E., Farrell R.S., et al. Detection with MR imaging of residual tumor in the breast soon after surgery. AJR Am J Roentgenol 1997, 168:485-488.